Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker
Authors:
Open Access
- 27 September 2021
- journal article
- research article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 17 (1) , 1-10
Abstract
Background: Thymidine kinase 1 (TK1) catalyzes the initial phosphorylation of thymidine in the salvage pathway synthesis of dTTP, an essential building block of DNA. TK1 is a cytosolic enzyme with its highest level during the S-phase of the cell cycle. In cancer cells TK1 is upregulated and excess TK1 is leaked into the blood. Therefore, serum TK1 has been used as biomarker for cancer diagnosis and prognosis in human medicine. Feline TK1 shows high sequence similarity to TK1 from other species. The aim of this study was to characterize feline TK1 and evaluate if serum TK1 can be used as a diagnostic biomarker. Results: Feline TK1 was cloned, expressed and affinity purified. The purified feline TK1 phosphorylated not only pyrimidine deoxyribonucleosides but also pyrimidine ribonucleosides and to some extent purine deoxynucleosides. A number of anticancer and antiviral nucleoside analogs also served as substrates with fairly high efficiency. ATP and dATP were the preferred phosphate donor. Serum TK1 activity in felines with malignant diseases was significantly higher than that in healthy individuals. ROC analysis revealed an area under the curve (AUC) of 0.98 with a sensitivity of 0.83 and a specificity of 0.95 for felines with lymphoma. Serum TK1 activity in felines with IBD or inflammatory disease was within the same range as healthy ones. Furthermore, in felines with lymphoma serum TK1 activity returned to normal levels in response to treatment. Conclusion: Feline TK1 has high specific activity and a broader substrate specificity in comparison with TK1 from other species. Serum TK1 activity in felines with malignant diseases is significantly higher than that in normal felines and in felines with inflammatory diseases. These results suggest that serum TK1 may be a promising biomarker for the diagnosis and monitoring of malignant diseases and for the differential diagnosis of certain inflammatory disease.Keywords
Funding Information
- Swedish University of Agricultural Sciences
This publication has 35 references indexed in Scilit:
- Elevation of serum thymidine kinase 1 in a bacterial infection: Canine pyometraTheriogenology, 2013
- A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphomaThe Veterinary Journal, 2012
- The proliferation marker thymidine kinase 1 in clinical useMolecular and Clinical Oncology, 2012
- Feline low-grade alimentary lymphoma: how common is it?Journal of Feline Medicine and Surgery, 2012
- Quaternary structures of recombinant, cellular, and serum forms of Thymidine Kinase 1 from dogs and humansBMC Biochemistry, 2012
- Serological Thymidine Kinase 1 is a Biomarker for Early Detection of Tumours—A Health Screening Study on 35,365 People, Using a Sensitive Chemiluminescent Dot Blot AssaySensors, 2011
- Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseasesVeterinary and Comparative Oncology, 2010
- Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assaysEuropean Journal of Cell Biology, 2009
- Mechanisms of substrate selectivity forBacillus anthracisthymidylate kinaseProtein Science, 2008
- Effect of C-Terminal of Human Cytosolic Thymidine Kinase (TK1) on in Vitro Stability and Enzymatic PropertiesNucleosides, Nucleotides & Nucleic Acids, 2006